Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Merck
Boehringer Ingelheim
Moodys
Colorcon
Baxter
Mallinckrodt

Last Updated: December 3, 2022

CLINICAL TRIALS PROFILE FOR GADOBENATE DIMEGLUMINE


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


All Clinical Trials for Gadobenate Dimeglumine

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00323310 ↗ Safety and Efficacy of MultiHance in Pediatric Patients Terminated Bracco Diagnostics, Inc Phase 3 2006-04-01 The purpose of this study was to assess the safety and enhancing properties of the magnetic resonance imaging (MRI) contrast agent MultiHance in children aged 2 to 17 years having central nervous system (CNS) disorders.
NCT00395863 ↗ Multihance at 3 Tesla (3T) in Brain Tumors Completed Bracco Diagnostics, Inc Phase 4 2006-11-01 Compare the efficacy of MultiHance and Magnevist
NCT01165892 ↗ Pulmonary MR Angiography and Lower Extremity MR Venous Imaging Using Gadofosveset (Ablavar) Completed Lantheus Medical Imaging 2011-07-01 The use of the contrast agent, Ablavar, will help with the diagnosis of pulmonary embolism in magnetic resonance imaging (MRI).
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Gadobenate Dimeglumine

Condition Name

Condition Name for Gadobenate Dimeglumine
Intervention Trials
Prostate Carcinoma 1
Adult Grade II Meningioma 1
Brain Neoplasm 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Gadobenate Dimeglumine
Intervention Trials
Brain Neoplasms 3
Nervous System Diseases 2
Central Nervous System Diseases 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Gadobenate Dimeglumine

Trials by Country

Trials by Country for Gadobenate Dimeglumine
Location Trials
United States 22
Belgium 1
Hungary 1
Mexico 1
China 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Gadobenate Dimeglumine
Location Trials
Illinois 3
Texas 2
Massachusetts 2
California 2
Michigan 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Gadobenate Dimeglumine

Clinical Trial Phase

Clinical Trial Phase for Gadobenate Dimeglumine
Clinical Trial Phase Trials
Phase 4 3
Phase 3 2
Phase 2 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Gadobenate Dimeglumine
Clinical Trial Phase Trials
Completed 7
Recruiting 4
Terminated 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Gadobenate Dimeglumine

Sponsor Name

Sponsor Name for Gadobenate Dimeglumine
Sponsor Trials
National Cancer Institute (NCI) 5
Bracco Diagnostics, Inc 5
Guerbet 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Gadobenate Dimeglumine
Sponsor Trials
Other 13
Industry 8
NIH 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Johnson and Johnson
Colorcon
Mallinckrodt
McKinsey
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.